The global human milk oligosaccharides market is expected to exhibit strong growth, reaching USD 800.6 million by 2030. As per the report titled "Human Milk Oligosaccharides Market Size, Share & Recession Impact Analysis, By Product Type (2’FL, 3’FL, 3’SL and 6’SL), By Application (Infant Formula, Functional Food & Beverage and Food Supplements), By Distribution Channel (Hypermarkets & Supermarkets, Drug Store or Pharmacy, Mass Merchandiser, Departmental Stores, Mono-brand Stores, Specialty Stores and Online Sales Channel), and Regional Forecasts, 2023-2030" observes that the market size in 2022 stood at USD 194.5 million and USD 800.6 million in 2030. The market is expected to exhibit a CAGR of 22.40% during the forecast period.
Jennewein Biotechnologie GmbH was Purchased by Chr. Hansen
In September 2020, Chr. Hansen purchased Jennewein Biotechnologie GmbH as well as a substantial collection of patents covering the creation of human milk oligosaccharides (HMOs) and various related legal disputes.
Growing Demand For Human Milk Oligosaccharides In Infant Formula To Spur Market Expansion
The need for Human Milk Oligosaccharides in infant formula is expected to drive market expansion. It is because human milk oligosaccharides have several benefits for the wellbeing of newborns. Human Milk Oligosaccharides are vital bioactive components in mother's milk that support the Bifidobacterium genus in people and promote the colonisation and growth of stomach microbial flora to benefit newborn health. Despite the fact that over 195 distinct Human Milk Oligosaccharides have been identified and ranked, a sizable number of them can be produced in sufficient quantities to be used in infant formula. Human milk oligosaccharides are advantageous to the digestive and immune systems.
Complex Industrial Process Of Extracting Oligosaccharides From Milk Will Limit Market Growth
Achieving a high level of purity is one of the most difficult tasks involved in creating large-scale or industrial systems to recover oligosaccharides from mammalian milk. More precisely, the difficulty is to eliminate simple carbohydrates like lactose, glucose, and galactose that lack prebiotic activities and may have negative consequences while still increasing product recovery. The recovery of oligosaccharides from milk using lactose hydrolysis and membrane filtering was effective; however, because the procedure is still laborious, it is necessary to introduce much more sophisticated and practical ways through rigorous techniques research and development operations.
Major Players Develop Acquisition Plans to Boost Brand Image
The leading businesses in the human milk oligosaccharides market plan acquisitions to improve their brand recognition globally. For instance, in March 2022, Health & Happiness (HH Group), a key nutrition company, announced that it is conducting ground-breaking research on how the correct combinations of human milk oligosaccharides and prebiotics, a form of prebiotics known as HMObiotics, could result in health benefits for clients of all ages.
Recent Development:
Jennewein Biotechnologie GmbH was Purchased by Chr. Hansen
In September 2020, Chr. Hansen purchased Jennewein Biotechnologie GmbH as well as a substantial collection of patents covering the creation of human milk oligosaccharides (HMOs) and various related legal disputes.
Growing Demand For Human Milk Oligosaccharides In Infant Formula To Spur Market Expansion
The need for Human Milk Oligosaccharides in infant formula is expected to drive market expansion. It is because human milk oligosaccharides have several benefits for the wellbeing of newborns. Human Milk Oligosaccharides are vital bioactive components in mother's milk that support the Bifidobacterium genus in people and promote the colonisation and growth of stomach microbial flora to benefit newborn health. Despite the fact that over 195 distinct Human Milk Oligosaccharides have been identified and ranked, a sizable number of them can be produced in sufficient quantities to be used in infant formula. Human milk oligosaccharides are advantageous to the digestive and immune systems.
Complex Industrial Process Of Extracting Oligosaccharides From Milk Will Limit Market Growth
Achieving a high level of purity is one of the most difficult tasks involved in creating large-scale or industrial systems to recover oligosaccharides from mammalian milk. More precisely, the difficulty is to eliminate simple carbohydrates like lactose, glucose, and galactose that lack prebiotic activities and may have negative consequences while still increasing product recovery. The recovery of oligosaccharides from milk using lactose hydrolysis and membrane filtering was effective; however, because the procedure is still laborious, it is necessary to introduce much more sophisticated and practical ways through rigorous techniques research and development operations.
Major Players Develop Acquisition Plans to Boost Brand Image
The leading businesses in the human milk oligosaccharides market plan acquisitions to improve their brand recognition globally. For instance, in March 2022, Health & Happiness (HH Group), a key nutrition company, announced that it is conducting ground-breaking research on how the correct combinations of human milk oligosaccharides and prebiotics, a form of prebiotics known as HMObiotics, could result in health benefits for clients of all ages.
Recent Development:
- In 2022, Merck Animal Health, formerly MSD Animal Health, has signed a legally binding contract under which it would acquire Vence from its owners and founders. For the management of cattle and rotational grazing, Vence is a pioneer in the use of virtual fencing.
List of Key Players Profiled in the Report
- Abbott Laboratories
- BASF S.E.
- Biosynth Carbosynth
- Chr. Hansen Holding A/S
- Dextra Laboratories Ltd.
- Dupont Nutrition & Biosciences
- Elicityl S.A.
- Glycom A/S
- Glycosyn
- Inbiose NV
- Medolac Laboratories
- Neolacta Lifesciences Pvt. Ltd
- Nestle Health Science
- Royal DSM
- ZuChem
Further Report Findings
- The market in North America is expected to gain a huge portion of the global Human milk oligosaccharides market share in the coming years because of the presence of significant industry players and the technological achievements of the area.
- As awareness among customers becomes more widespread, especially in the U.S., health benefits of HMOs are one of the key factors promoting market growth in the field.
- In the Asia Pacific, the growth in this region is primarily driven by adoption of healthy lifestyles in line with the growing trend of health consciousness.
| Attributes | Details |
| Market Size in 2022 | USD 194.5 Billion |
| Market Forecast in 2030 | USD 800.6 Billion |
| Compound Annual Growth Rate | 22.40 % |
| Unit | Revenue (USD Million) and Volume (Kilo Tons) |
| Segmentation | By Type, By Application, By Distribution Channel and By Geography |
| By Type |
|
| By Application |
|
| By Distribution Channel |
|
| By Region |
|
| Base Year | 2022 |
| Historical Year | 2016-2021 |
| Forecast Year | 2023-2030 |
